智通财经APP获悉，微创机器人-B(02252)盘中涨超8%，近三个交易日累涨超四成。截至发稿，涨7.15%，报15.28港元，成交额2.15亿港元。
消息面上，微创机器人发布公告称，根据内部初步统计数据，去年集团旗下腔镜、骨科、血管介入核心产品的综合订单量已累计超过100台。当中，图迈腔镜手术机器人全球订单达39台，商业化装机突破30台，全球累计商业化订单近60台，图迈已在20多个国家或地区提交上市认证申请，预计今年将密集获批。另外，鸿鹄骨科手术机器人全球订单达25台，累计订单超过40台。R-ONE血管介入机器人为目前唯一一款在中国国内上市并销售的冠脉介入手术机器人产品。2024年12月，R-ONE中标复旦大学附属中山医院等 5家上海头部公立医院的采购订单，国内订单达8台及全球18台。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.